Balyasny Asset Management
RXST icon

Balyasny Asset Management’s RxSight RXST Stock Holding History

Balyasny Asset Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$276K Sell
44,793
-37,043
-45% -$308K ﹤0.01% 2593
2025
Q4 		$853K Sell
81,836
-252,341
-76% -$2.53M ﹤0.01% 2264
2025
Q3 		$3M Buy
+334,177
New +$2.93M ﹤0.01% 1615
2025
Q2 		– Sell
-160,627
Closed -$4.06M – 3277
2025
Q1 		$4.06M Buy
160,627
+136,649
+570% +$4.06M 0.01% 1355
2024
Q4 		$824K Buy
+23,978
New +$1.08M ﹤0.01% 2011

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Balyasny Asset Management's RXST Position: Q1 2026 in Review

Balyasny Asset Management reduced its RxSight (RXST) stake by 45% in Q1 2026, selling an estimated $308K and leaving 44,793 shares worth $276K. The position accounts for ﹤0.01% of the portfolio, ranked #2593.

Balyasny Asset Management first reported a position in RXST in Q4 2024 and has held it in 5 quarters since. The position peaked at $4.06M in Q1 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Balyasny Asset Management held 44,793 shares of RxSight worth $276K as of Q1 2026.
  • Balyasny Asset Management sold 37,043 RxSight shares in Q1 2026, an estimated $308K.
  • RxSight made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2593 holding.
  • Balyasny Asset Management first reported a position in RxSight in Q4 2024 and has held it in 5 quarters since.
  • Balyasny Asset Management's RxSight position peaked at $4.06M in Q1 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.